These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12214931)

  • 1. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration.
    Dowidar N; Hafez A
    J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic variceal sclerotherapy in patients with Symmers periportal fibroses.
    Mudawi HM; Ibrahim KB
    Trop Doct; 2007 Jul; 37(3):179-81. PubMed ID: 17716514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
    Neeman A; Leiser A; Kadish U
    Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients.
    Krige JE; Bornman PC; Goldberg PA; Terblanche J
    Arch Surg; 2000 Nov; 135(11):1315-22. PubMed ID: 11074888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic sclerotherapy for bleeding oesophageal varices: experience in Sudan.
    Gasim B; Fedail SS; Musaad AM; Salih SM; Ibn-Ouf M
    Trop Gastroenterol; 2002; 23(2):107-9. PubMed ID: 12632985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of bleeding esophago-gastric varices].
    Oho K; Toyonaga A
    Nihon Rinsho; 1998 Sep; 56(9):2325-30. PubMed ID: 9780714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating the effect of adjuvant propranolol therapy.
    Dowidar N; Hafez A; Abdel Baki M
    J Egypt Soc Parasitol; 2005 Dec; 35(3):773-86. PubMed ID: 16333887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.
    Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H
    Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate.
    Kitano S; Koyanagi N; Iso Y; Higashi H; Sugimachi K
    Hepatology; 1987; 7(5):810-5. PubMed ID: 3498673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanolamine oleate versus absolute alcohol as a variceal sclerosant: a prospective, randomized, controlled trial.
    Sarin SK; Mishra SP; Sachdev GK; Thorat V; Dalal L; Broor SL
    Am J Gastroenterol; 1988 May; 83(5):526-30. PubMed ID: 3284336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized controlled trial comparing sodium tetradecyl sulphate and ethanolamine oleate in the sclerotherapy of bleeding oesophageal varices.
    Chan AC; Chung SC; Sung JY; Leung JW; Li AK
    Endoscopy; 1993 Oct; 25(8):513-7. PubMed ID: 8287811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: a comparative study.
    Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Inoue H; Morita Y; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 60(3-4):105-13. PubMed ID: 24858411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
    Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
    Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic sclerotherapy of bleeding esophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis.
    Sakai P; Boaventura S; Capacci ML; Macedo TM; Ishioka SZ
    Endoscopy; 1988 Jul; 20(4):134-6. PubMed ID: 3263266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy.
    Gotoh Y; Iwakiri R; Sakata Y; Koyama T; Noda T; Matsunaga C; Ogata SI; Ishibashi S; Sakata H; Tsunada S; Fujimoto K
    J Gastroenterol Hepatol; 1999 Mar; 14(3):241-4. PubMed ID: 10197493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
    Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
    J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
    Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
    Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotherapy for gastric fundal variceal bleeding: is complete obliteration possible without cyanoacrylate?
    Kojima K; Imazu H; Matsumura M; Honda Y; Umemoto N; Moriyasu H; Orihashi T; Uejima M; Morioka C; Komeda Y; Uemura M; Yoshiji H; Fukui H
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1701-6. PubMed ID: 16246189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia.
    Horigome H; Nomura T; Saso K; Hashimoto T; Suzuki T; Joh T; Ohara H; Akita S; Sobue S; Mizuno Y; Kato Y; Ohmi H; Itoh M
    Hepatogastroenterology; 1999; 46(30):3060-2. PubMed ID: 10626160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.